Exercise-induced changes in circulating levels of transforming growth factor-β-1 in humans: Methodological considerations

European Journal of Applied Physiology

Volumn 90, Issue 1-2, 2003, Pages 171-177

  Heinemeier, Katja ^a   Langberg, Henning ^a   Kjaer, Michael ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Exercise; Plasma; Platelets; TGF 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; BLOOD SAMPLING; CELL GRANULE; CENTRIFUGATION; CONTROLLED STUDY; COOLING; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MUSCLE FUNCTION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE ACTIVATION;

ADULT; BLOOD CHEMICAL ANALYSIS; BLOOD VOLUME; EXERCISE; FEMALE; HUMANS; MALE; REPRODUCIBILITY OF RESULTS; REST; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0242551181     PISSN: 14396319     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00421-003-0881-8     Document Type: Article

References (41)

1. Assoian RK, Sporn MB (1986) Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol 102 (4):1217-1223
2. Bitzer M, Sterzel RB, Bottinger EP (1998) Transforming growth factor-beta in renal disease. Kidney Blood Press Res. 21 (1):1-12
3. Bonewald LF (1999) Regulation and regulatory activities of transforming growth factor beta. Crit Rev Eukaryot Gene Exp 9 (1):33-44
4. Cillo JE Jr., Gassner R, Koepsel RR, Buckley MJ (2000) Growth factor and cytokine gene expression in mechanically strained human osteoblast-like cells: implications for distraction osteogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 90 (2):147-154
5. Cucina A, Sterpetti AV, Borrelli V, Pagliei S, Cavallaro A, D'Angelo LS (1998) Shear stress induces transforming growth factor-beta 1 release by arterial endothelial cells. Surgery 123 (2):212-217
6. Drygas WK (1988) Changes in blood platelet function, coagulation, and fibrinolytic activity in response to moderate, exhaustive, and prolonged exercise. Int J Sports Med 9 (1):67-72
7. Flisiak R, Pytel-Krolczuk B, Prokopowicz D (2000) Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis. Cytokine 12 (6):677-681
8. Gleizes PE, Munger JS, Nunes I, Harpel JG, Mazzieri R, Noguera I, Rifkin DB (1997) TGF-beta latency: biological significance and mechanisms of activation. Stem Cells 15 (3):190-197
9. Grainger DJ, Mosedale DE, Metcalfe JC (2000) TGF-beta in blood: a complex problem. Cytokine Growth Factor Rev 11 (12):133-145
10. Gutierrez JA, Perr HA (1999) Mechanical stretch modulates TGF-beta1 and alphal(1) collagen expression in fetal human intestinal smooth muscle cells. Am J Physiol 277 (5 Pt 1): G1074-G1080
11. Hayasaka A, Suzuki N, Fukuyama E, Kanda Y (1996) Plasma levels of transforming growth factor beta 1 in chronic liver disease. Clin Chim Acta 244 (1):117-119
12. Heinemeier K (2002) Role of transforming growth factor in relation to exercise-induced type I collagen synthesis in human tendinous tissue. Master Thesis, Faculty of Health Sciences, University of Copenhagen, pp 1-106
13. Hering S, Jost C, Schulz H, Hellmich B, Schatz H, Pfeiffer H (2002) Circulating transforming growth factor beta1 (TGFbeta1) is elevated by extensive exercise. Eur J Appl Physiol 86 (5):406-410
14. Higley H, Persichitte K, Chu S, Waegell W, Vancheeswaran R, Black C (1994) Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon. Arthritis Rheum 37 (2):278-288
15. Ignotz RA, Massague J (1986) Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261 (9):4337-4345
16. Ishitobi M, Haginoya K, Zhao Y, Ohnuma A, Minato J, Yanagisawa T, Tanabu M, Kikuchi M, Iinuma K (2000) Elevated plasma levels of transforming growth factor beta1 in patients with muscular dystrophy. Neuroreport 11 (18):4033-4035
17. Junker U, Knoefel B, Nuske K, Rebstock K, Steiner T, Wunderlich H, Junker K, Reinhold D (1996) Transforming growth factor beta 1 is significantly elevated in plasma of patients suffering from renal cell carcinoma. Cytokine 8 (10):794-798
18. Kong FM, Anscher MS, Murase T, Abbott BD, Iglehart JD, Jirtle RL (1995) Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor. Ann Surg 222 (2):155-162
19. Kropf J, Schurek JO, Wollner A, Gressner AM (1997) Immunological measurement of transforming growth factor-beta 1 (TGF-beta1) in blood; assay development and comparison. Clin Chem 43 (10):1965-1974
20. Lev PR, Marta RF, Vassallu P, Molinas FC (2002) Variation of PDGF, TGFbeta, and bFGF levels in essential thrombocythemia patients treated with anagrelide. Am J Hematol 70 (2):85-91
21. Li YY, McTiernan CF, Feldman AM (2000) Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc Res 46 (2):214-224
22. Lijnen PJ, Petrov VV, Fagard RH (2000) Induction of cardiac fibrosis by transforming growth factor-beta(1). Mol Genet Metab 71 (1-2):418-435
23. Mody M, Lazarus AH, Semple JW, Freedman J (1999) Preanalytical requirements for flow cytometric evaluation of platelet activation: choice of anticoagulant. Transfus Med 9 (2):147-154
24. Murase T, Jirtle RL, McDonald GB (1994) Transforming growth factor-beta plasma concentrations in patients with leukemia and lymphoma receiving chemoradiotherapy and marrow transplantation. Blood 83 (8):2383
25. Narai S, Watanabe M, Hasegawa H, Nishibori H, Endo T, Kubota T, Kitajima M (2002) Significance of transforming growth factor beta1 as a new tumor marker for colorectal cancer. Int J Cancer 97 (4):508-511
26. O'Callaghan CJ, Williams B (2000) Mechanical strain-induced extracellular matrix production by human vascular smooth muscle cells: role of TGF-beta(1). Hypertension 36 (3):319-324
27. Ogasawara MS, Aoki K, Aoyama T, Katano K, Iinuma Y, Ozaki Y, Suzumori K (2000) Elevation of transforming growth factor-beta1 is associated with recurrent miscarriage. J Clin Immunol 20 (6):453-457
28. Pedersen BK, Hoffman-Goetz L (2000) Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 80 (3):1055-1081
29. Prud'homme GJ, Piccirillo CA (2000) The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases. J Autoimmun 14 (1):23-42
30. Robbins JR, Evanko SP, Vogel KG (1997) Mechanical loading and TGF-beta regulate proteoglycan synthesis in tendon. Arch Biochem Biophys 342 (2):203-211
31. Ruwhof C, van Wamel AE, Egas JM, van der LA (2000) Cyclic stretch induces the release of growth promoting factors from cultured neonatal cardiomyocytes and cardiac fibroblasts. Mol Cell Biochem 208 (1-2):89-98
32. Shariat SF, Shalev M, Menesses-Diaz A, Kim IY, Kattan MW, Wheeler TM, Slawin KM (2001) Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy. J Clin Oncol 19 (11):2856-2864
33. Shirai Y, Kawata S, Tamura S, Ito N, Tsushima H, Takaishi K, Kiso S, Matsuzawa Y (1994) Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases. Cancer 73 (9):2275-2279
34. Skutek M, van Griensven M, Zeichen J, Brauer N, Bosch U (2001) Cyclic mechanical stretching modulates secretion pattern of growth factors in human tendon fibroblasts. Eur J Appl Physiol 86 (1):48-52
35. Suzuki K, Yamada M, Kurakake S, Okamura N, Yamaya K, Liu Q, Kudoh S, Kowatari K, Nakaji S, Sugawara K (2000) Circulating cytokines and hormones with immunosuppressive but neutrophil-priming potentials rise after endurance exercise in humans. Eur J Appl Physiol 81 (4):281-287
36. Szymkowiak CH, Mons I, Gross WL, Kekow J (1995) Determination of transforming growth factor beta 2 in human blood samples by ELISA. J Immunol Methods 184 (2):263-271
37. van Beaumont W, Strand JC, Petrofsky JS, Hipskind SG, Greenleaf JE (1973) Changes in total plasma content of electrolytes and proteins with maximal exercise. J Appl Physiol 34 (1):102-106
38. Villarreal FJ, Dillmann WH (1992) Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen. Am J Physiol 262 (6 Pt 2):H1861-H1866
39. Wakefield LM, Letterio JJ, Chen T, Danielpour D, Allison RS, Pai LH, Denicoff AM, Noone MH, Cowan KH, O'Shaughnessy JA (1995) Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. Clin Cancer Res 1 (1):129-136
40. Wiercinska-Drapalo A, Flisiak R, Prokopowicz D (2001) Effect of ulcerative colitis activity on plasma concentration of transforming growth factor beta1. Cytokine 14 (6):343-346
41. Yasuda T, Kondo S, Homma T, Harris RC (1996) Regulation of extracellular matrix by mechanical stress in rat glomerular mesangial cells. J Clin Invest 98 (9):1991-2000